Angiogenin Released from ABCB5+ Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis.

Singh, Karmveer; Maity, Pallab; Kallon Koroma, Albert; Basu, Abhijit; Kumar Pandey, Rajeev; Vander Beken, Seppe; Haas, Philipp; Krug, Linda; Hainzl, Adelheid; Sindrilaru, Anca; Pfeiffer, Christiane; Wlaschek, Meinhard; Y Frank, Natasha; H Frank, Markus; Ganss, Christoph; Bánvölgyi, András; Wikonkál, Norbert; Eming, Sabine; Pastar, Irena; Tomic-Canic, Marjana; A Kluth, Mark; Scharffetter-Kochanek, Karin

doi:10.1016/j.jid.2021.10.026

Public

Angiogenin Released from ABCB5+ Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis.

Published in The Journal of investigative dermatology • Jun 1, 2022

NobleIDark:/48914/w1/20260526/0EEC2441Record on NobleID

Authors:

Karmveer Singh

,

Pallab Maity

,

Albert Kallon Koroma

Abstract

Severe angiopathy is a major driver for diabetes-associated secondary complications. Knowledge on the underlying mechanisms essential for advanced therapies to attenuate these pathologies is limited. Injection of ABCB5+ stromal precursors at the edge of nonhealing diabetic wounds in a murine db/db m...

Discussions